Riskpilot← Back to searchSign inGet full accessBrosjö Medical AB
ABActiveOrg 5568950041Toivovägen 69General medical practice activities · NACE 8621Est. 20120 employees
Revenue 2024
SEK 526K
-2% vs 2023
EBITDA margin
74.5%
-15% vs 2023
Equity ratio
97.3%
Financial strength
Net profit 2024
SEK 470K
+188% vs 2023
| Revenue | SEK 526K | -2% |
| EBITDA | SEK 392K | -15% |
| Net profit | SEK 470K | +188% |
| Total assets | SEK 4,5M | +11% |
| Equity | SEK 4,4M | +12% |
| Employees | 0 | — |
Legal name
Brosjö Medical AB
Org number
5568950041
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 juni 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Brosjö, Eva Birgitta Brosjö, Otte
Company purpose
Föremålet för bolagets verksamhet är att verka inom försäkrings- medicin, utbildning och kursverksamhet ävensom bedriva verksamhet inom området betonggjutning av konst- och bruksföremål, och därmed förenlig verksamhet.
Address
Toivovägen 69
Phone
+46707292723
Email
otte.brosjo@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 510 | 545 | 516 | 538 | 526 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 359 | 1 492 | 410 | 459 | 392 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 359 | 1 492 | 410 | 459 | 392 |
| Net financials | 21 | −33 | −768 | −80 | 202 |
| Profit before tax | 504 | 1 597 | −36 | 379 | 594 |
| Tax | −128 | −330 | −0 | −216 | −124 |
| Net profit | 376 | 1 267 | −36 | 163 | 470 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 114 | 4 415 | 3 900 | 4 063 | 4 517 |
| Equity | 2 530 | 3 797 | 3 761 | 3 924 | 4 395 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 124 | 296 | 139 | 138 | 123 |
| Total debt | 124 | 296 | 139 | 138 | 123 |
EBITDA margin
74.5%
This company
15.8%
Market median
+372% vs market
20202024
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20202024
Return on equity
10.7%
This company
18.4%
Market median
+42% vs market
20202024
Net profit margin
89.4%
This company
8.1%
Market median
+1004% vs market
20202024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EB Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Brosjö Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Birgitta Brosjö | Deputy Chief Executive Officer | 0 companies |
| Marcus Olle Brosjö | Board of Directors | 0 companies |
| Otte Brosjö | Chairman | 0 companies |
| Niklas Erik Brosjö | Board of Directors | 0 companies |